AbbVie Inc. (BKK:ABBV19)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of THB 12.75 trillion. The enterprise value is 14.71 trillion.

Market Cap	12.75T
Enterprise Value	14.71T

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Jan 16, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.24%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 96.56 and the forward PE ratio is 15.94.

PE Ratio	96.56
Forward PE	15.94
PS Ratio	6.61
PB Ratio	-125.22
P/TBV Ratio	n/a
P/FCF Ratio	22.69
P/OCF Ratio	21.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 26.18.

EV / Earnings	111.43
EV / Sales	7.74
EV / EBITDA	15.97
EV / EBIT	22.43
EV / FCF	26.18

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	33.84M
Profits Per Employee	2.32M
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 74.55 billion in taxes.

Income Tax	74.55B
Effective Tax Rate	35.83%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	7.04
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.20
Average Volume (20 Days)	36,537

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, AbbVie had revenue of THB 1.93 trillion and earned 132.01 billion in profits. Earnings per share was 74.43.

Revenue	1.93T
Gross Profit	1.38T
Operating Income	665.90B
Pretax Income	208.05B
Net Income	132.01B
EBITDA	922.58B
EBIT	665.90B
Earnings Per Share (EPS)	74.43

Balance Sheet

The company has 165.79 billion in cash and 2.16 trillion in debt, with a net cash position of -1,991.34 billion.

Cash & Cash Equivalents	165.79B
Total Debt	2.16T
Net Cash	-1,991.34B
Net Cash Per Share	n/a
Equity (Book Value)	-101.80B
Book Value Per Share	-58.33
Working Capital	-448.68B

Cash Flow

In the last 12 months, operating cash flow was 600.15 billion and capital expenditures -38.29 billion, giving a free cash flow of 561.86 billion.

Operating Cash Flow	600.15B
Capital Expenditures	-38.29B
Free Cash Flow	561.86B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 1.20%.

Dividend Per Share	0.09
Dividend Yield	1.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	1.20%
Earnings Yield	1.04%
FCF Yield	4.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8